Home > Healthcare > Medical Devices > Surgical Devices > Heart Closure Devices Market

Heart Closure Devices Market Trends

  • Report ID: GMI6140
  • Published Date: Jul 2023
  • Report Format: PDF

Heart Closure Devices Market Trends

Heart closure devices have witnessed significant technological advancements in recent years. Novel bioabsorbable closure devices are designed to provide temporary support for wound closure and subsequently degrade or absorb within the body. These devices eliminate the need for a second procedure to remove sutures or metal clips, reducing patient discomfort and the risk of complications. Magnetic closure devices are an emerging technology for closing surgical incisions in cardiovascular procedures. These devices use magnets to hold the edges of an incision together, allowing for a less invasive closure method compared to traditional sutures or staples. The magnets can be adjusted externally, allowing for precise control over the closure.
 

Magnetic closure devices have the potential to reduce scarring and promote faster wound healing. Moreover, suture-mediated closure devices have been developed to facilitate the closure of large arterial access sites after minimally invasive cardiac procedures. These devices consist of a collagen plug or other materials that are deployed at the site of arterial puncture. Suture-mediated closure devices provide a secure closure and can potentially reduce the time required for post-procedure bed rest. Overall, technological advancements hold promise in improving heart closure devices performance efficiently.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of heart closure devices was reached USD 2.2 billion in 2022 and is estimated to be worth more than USD 6.6 billion by 2032, due to the growing prevalence of cardiovascular diseases and higher adoption of minimally invasive procedures.

The left atrial appendage (LAA) closure devices product segment is projected to generate more than USD 2.9 billion by 2032, owing to several advantages associated with these devices in the heart closure treatment procedures.

U.S. market is estimated to expand at a notable pace and amass more than USD 2.7 billion by 2032 driven by the strong presence of major industry players, scaling demand for heart closure procedures, and the high prevalence of cardiovascular conditions.

Some of the top companies operating in the industry are Abbott Laboratories, AtriCure Inc., Biosense Webster, Inc., Boston Scientific Corporation, and Cardia, Inc.

Heart Closure Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 452
  • Countries covered: 30
  • Pages: 180
 Download Free Sample